Queensland researchers and a US team have developed an antiviral therapy that goes on a "seek and destroy mission" where the therapy genetically targets the coronavirus in the body, and if the next stage of clinical trials go ahead it could be available some time in 2032.
Subscribe: [ Ссылка ] Read more here: [ Ссылка ]
Lead researcher Professor Nigel McMillan, from Griffith University, called it a "seek and destroy mission" where the therapy genetically targeted the potentially deadly virus.
The international team of scientists from the Menzies Health Institute Queensland and the US research institute City of Hope began their collaborative research last April.
They used a "next-generation" viral approach using gene-silencing RNA technology to attack the virus genome directly, which stops the virus spreading.
"It causes the genome to be destroyed and the virus can't grow anymore — so we inject the nanoparticles and they go and find the virus and destroy it just like a heat-seeking missile," Professor McMillan said.
"This is the first time we have been able to package this up as a particle, send it through the blood stream to attack the virus.
"It travels to the lungs and it will actually enter all the lung cells, but only in the lung cells with the virus will it destroy — normal cells are completely unharmed by this treatment."
#COVIDAntiviralTherapy #QueenslandNews
ABC News provides around the clock coverage of news events as they break in Australia and abroad, including the latest coronavirus pandemic updates. It's news when you want it, from Australia's most trusted news organisation.
For more from ABC News, click here: [ Ссылка ]
Watch more ABC News content ad-free on iview: [ Ссылка ]
Go deeper on our ABC News In-depth channel: [ Ссылка ]
Like ABC News on Facebook: [ Ссылка ]
Follow ABC News on Instagram: [ Ссылка ]
Follow ABC News on Twitter: [ Ссылка ]
#ABCNews #ABCNewsAustralia
